Discover
PRME
Prime Medicine, Inc.
3.12
2 x 2.24
2 x 3.71
bid
ask
-
0.02
0.64%
2 @ 07:50 PM
3.15 +0.03 (0.96%)
| Ytd | -10.09% | |
| 1y | -39.06% |
3.04
day range
3.17
2.70
52 week range
6.67
| Open | 3.13 | Prev Close | 3.14 | Low | 3.04 | High | 3.17 | Mkt Cap | 565.90M |
| Vol | 4.67M | Avg Vol | 3.28M | EPS | -1.05 | P/E | N/A | Forward P/E | -3.96 |
| Beta | 2.67 | Short Ratio | 5.85 | Inst. Own | 44.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-06 | 50-d Avg | 3.26 | 200-d Avg | 3.53 | 1yr Est | 6.50 |
| Income Statement | |||
| Total Revenue | 1.15M | ||
| Revenues (USD) | 1.15M | ||
| Gross Profit | 1.15M | ||
| Operating Expenses | 44.44M | ||
| Research and Development Expense | 33.40M | ||
| Selling, General and Administrative Expense | 11.04M | ||
| Operating Income | -43.28M | ||
| Net Income | -42.11M | ||
| Net Income Common Stock | -42.11M | ||
| Net Income Common Stock (USD) | -42.11M | ||
| Consolidated Income | -42.11M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -42.11M | ||
| Earning Before Interest & Taxes (USD) | -42.11M | ||
| Weighted Average Shares | 177.22M | ||
| Weighted Average Shares Diluted | 177.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.14M | ||
| Cash and Equivalents (USD) | 61.14M | ||
| Investments | 47.62M | ||
| Investments Current | 47.62M | ||
| Current Assets | 96.80M | ||
| Property, Plant & Equipment Net | 137.54M | ||
| Total Assets | 249.04M | ||
| Debt Current | 8.97M | ||
| Total Debt | 112.48M | ||
| Current Liabilities | 31.69M | ||
| Debt Non-Current | 103.51M | ||
| Total Liabilities | 209.23M | ||
| Accumulated Retained Earnings (Deficit) | -979.58M | ||
| Accumulated Other Comprehensive Income | -9.00K | ||
| Shareholders Equity | 39.81M | ||
| Shareholders Equity (USD) | 39.81M | ||
| Assets Non-Current | 152.24M | ||
| Total Debt (USD) | 112.48M | ||
| Deferred Revenue | 63.97M | ||
| Liabilities Non-Current | 177.54M | ||
| Trade and Non-Trade Payables | 5.81M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.65M | ||
| Net Cash Flow from Financing | 361.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.65M | ||
| Capital Expenditure | -46.00K | ||
| Issuance (Purchase) of Equity Shares | 361.00K | ||
| Net Cash Flow from Investing | 24.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 24.08M | ||
| Net Cash Flow from Operations | -41.05M | ||
| Share Based Compensation | 4.87M | ||